Endonovo Therapeutics Inc. (ENDV) 1.0000 $ENDV
Endonovo Therapeutics Targets Non-Invasive Treatment for Acute and Chronic Inflammatory Conditions of the Liver
PR Newswire - Wed Apr 08, 8:00AM CDT
LOS ANGELES, April 8, 2015 /PRNewswire/-- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"
, a biotechnology company developing non-invasive, bio-electromagnetic products with anti-inflammatory properties designed to promote regeneration in damaged tissue and organs in animals and humans, today announced its intention to begin pre-clinical testing of its electroceutical technology to treat and reverse acute and chronic inflammatory liver pathologies. This includes the conditions that cause nonalcoholic steatohepatitis (NASH) and human cirrhotic liver disease.
Endonovo Therapeutics Enters into a $3 Million Equity Purchase Agreement with Kodiak Capital Group, LLC
Business Wire - Wed Jan 21, 7:30AM CST
Endonovo Therapeutics, Inc. (OTCQB:ENDV) ("Endonovo" or the "Company", a biotechnology company developing innovative regenerative therapies, today announced that it has entered into a $3 million equity purchase agreement with Kodiak Capital Group, LLC, a California-based institutional investor.
Endonovo Therapeutics Receives Final Commissioned Report Recommendations Regarding FDA Regulatory Pathway for Urinary Incontinence Treatment
Marketwired - Tue Dec 02, 8:06AM CST
Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company", a biotechnology company developing innovative regenerative therapies, has received a final report from Emergo Group, Inc. ("Emergo" that reviewed, classified and recommended Endonovo's strategy for gaining FDA 510K regulatory clearance of their proprietary bioelectronic technology for the treatment of urinary incontinence in women.
AMGN: 163.38 (+1.89)
Endeavour Announces Accelerated Schedule for Chapter 11 Court Hearings and Resignation of William L. Transier as President and Chief Executive Officer
PR Newswire - Thu Nov 13, 3:10PM CST
Endeavour International Corporation (OTC: ENDRQ) (LSE: ENDV) today announced an accelerated timetable for its Chapter 11 proceedings. The Company anticipates scheduling the following hearing dates with the United States Bankruptcy Court for the District of Delaware:
Endeavour Obtains Final Stock and Claims Order for Trading Requirements
PR Newswire - Fri Nov 07, 6:44PM CST
Endeavour International Corporation (OTC: ENDRQ) (LSE: ENDV) announced today that on November 6, 2014, it and certain of its subsidiaries, including Endeavour Operating Corporation (collectively, the "Debtors", obtained a final order (the "Order" from the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court", effective as of October 10, 2014, (i) restricting certain transfers of interest in Endeavour common stock and preferred stock and, depending on the Debtors' proposed chapter 11 plan when filed, certain transfers of claims against the Debtors, and (ii) imposing certain notification requirements with respect to substantial owners of Endeavour stock (by class) and substantial owners of claims against the Debtors (namely, Endeavour's 12% First Priority Notes, its 12% Second Priority Notes, and any unsecured claims against the Debtors). The Bankruptcy Court had previously entered an order on an interim basis. The Order is intended to prevent certain transfers of stock of Endeavour and certain transfers of claims against the Debtors that could impair the ability of one or more of the Debtors' estates to use, to the extent otherwise available, their net operating loss carryovers and certain other tax attributes during bankruptcy and on a reorganized basis.
Endeavour Obtains Interim Stock and Claims Order for Trading Requirements
PR Newswire - Fri Oct 17, 4:45PM CDT
Endeavour International Corporation (OTC: ENDRQ) (LSE: ENDV) announced today that on October 10, 2014, it and certain of its subsidiaries, including Endeavour Operating Corporation (collectively, the "Debtors", filed a motion (the "Motion" with the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court" seeking an order (i) restricting certain transfers of interest in Endeavour common stock and preferred stock and, depending on the Debtors' proposed chapter 11 plan when filed, certain transfers of claims against the Debtors, and (ii) imposing certain notification requirements with respect to substantial owners of Endeavour stock (by class) and substantial owners of claims against the Debtors (namely, Endeavour's 12% First Priority Notes, its 12% Second Priority Notes, and any unsecured claims against the Debtors). The order is intended to prevent certain transfers of stock of Endeavour and certain transfers of claims against the Debtors that could impair the ability of one or more of the Debtors' estates to use, to the extent otherwise available, their net operating loss carryovers and certain other tax attributes during bankruptcy and on a reorganized basis.
Endeavour Announces Rochelle Field Has Returned to Production
PR Newswire - Wed Oct 15, 9:30AM CDT
Endeavour International Corporation (OTC Pink: ENDRQ) (LSE: ENDV) today announced that the Rochelle field is back online. Production from the field restarted on October 12, 2014 and is currently producing at 90 million standard cubic feet of gas per day ("MMscf/d" with approximately 4,600 barrels of per day of associated liquids.
Endeavour Executes Restructuring Support Agreement Pursuant to Chapter 11 Proceedings
PR Newswire - Fri Oct 10, 10:51PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that the Company has executed a Restructuring Support Agreement ("RSA" with holders of more than two-thirds (2/3) of its 12% First Priority Notes, 12% Second Priority Notes, 7.5% Convertible Bonds and 5.5% / 6.5% Convertible Notes (collectively, the "Notes" to restructure the Company's debt obligations. In connection therewith, the Company and certain of its subsidiaries have each filed a voluntary petition for relief under Chapter 11 of the Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware ("Chapter 11 Proceedings". The Company's U.K. subsidiaries and certain other affiliates have not sought bankruptcy protection and will continue to operate outside of any reorganization proceedings. Endeavour and its debtor affiliates will continue to operate as "debtors in possession" in the Chapter 11 Proceedings.
Endeavour Announces One Day Forbearance Agreement with Noteholders
PR Newswire - Thu Oct 09, 8:00PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that the Company and certain of its subsidiaries have entered into extensions of their forbearance agreements (the "Forbearance Agreements" with holders of a majority of its 12% First Priority Notes due 2018, 12% Second Priority Notes due 2018 and 6.5% Convertible Senior Notes due 2016 (collectively, the "Notes".
Endeavour Announces the Appointment of a Chief Restructuring Officer
PR Newswire - Mon Oct 06, 4:00PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that the Company has engaged Opportune LLP, to assist the company in its financial restructuring process. In connection with this engagement, David C. Baggett, Managing Partner of Opportune LLP, has been appointed as Chief Restructuring Officer of Endeavour, effective immediately, reporting directly to the Board of Directors.
GEL: 45.84 (+0.19)
Endeavour International Corporation Announces Closing of $440 Million Senior Secured First Lien Term Loan and Forbearance Agreement with Noteholders
PR Newswire - Wed Oct 01, 1:00AM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced the closing of a $440 million senior secured term loan (the "Credit Agreement" with an annual interest rate of LIBOR plus 10% (with a LIBOR floor of 1%), that matures on January 2, 2017. The proceeds of the financing were used to repay the balance outstanding under the Company's existing credit agreement, dated as of January 24, 2014, to repay in full certain monetary production payments issued by the Company's wholly-owned subsidiary, Endeavour Energy UK Limited ("EEUK", to repay all reimbursement obligations outstanding with respect to the Company's existing LC Procurement Agreement, dated as of January 24, 2014, to provide cash collateral under the terms of a new LC Issuance Agreement entered into by certain subsidiaries of the Company (pursuant to which Credit Suisse AG has agreed to issue letters of credit for EEUK's account to secure decommissioning obligations in connection with certain of its United Kingdom Continental Shelf Petroleum Production Licenses), for payment of related expenses and to provide additional liquidity to the Company.
Endeavour Announces Rochelle Field Remains Offline
PR Newswire - Fri Sep 26, 3:30PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that it has been informed by the operator of the Scott platform that the Rochelle field remains offline. Although the repairs of the Scott export compressors were successfully completed, the gas cooler failed a leak test during commissioning.
Endeavour Receives Notice Regarding NYSE Continued Listing Standards
PR Newswire - Wed Sep 17, 3:30PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) announced today that the New York Stock Exchange ("NYSE" has notified the Company that it is not in compliance with two of the NYSE's continued listing standards.
Endeavour Announces Rochelle Field Offline
PR Newswire - Mon Sep 15, 3:30PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that the Rochelle field is offline until repairs to the dry gas export compressors on the Scott platform are completed.
Endeavour Announces Decision Not to Make Interest Payments
PR Newswire - Tue Sep 02, 3:05PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that it has decided not to pay approximately $33.5 million in interest due on September 2, 2014 on its 12% First Priority Notes due March 2018, 12% Second Priority Notes due June 2018 and 6.5% Convertible Senior Notes due November 2017 ("collectively, the Notes". Under the term of the indentures for the Notes, there is a 30-day grace period during which the Company may elect to make the interest payment and cure any potential event of default for non-payment.
Endonovo Therapeutics Files Patent on Bioelectronic Technology, Devices and Therapies
Marketwire - Tue Sep 02, 8:02AM CDT
Endonovo Therapeutics, Inc. (OTCQB: ENDV), a developer of novel cell-free therapies, announced today that it has filed a patent on bioelectronic technologies, devices and therapies (the "Technology".
Endonovo Therapeutics Developing Non-Invasive Bioelectronic Therapy for Urinary Incontinence
Marketwire - Thu Aug 14, 8:03AM CDT
Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company", a developer of non-invasive bioelectronic therapies, announced today that it has retained Holland & Knight, LLP ("H & K" as its legal counsel and Emergo Group, Inc. ("Emergo" to assist the Company in obtaining FDA clearance of its non-invasive urinary incontinence treatment.
Endeavour to Present at EnerCom's The Oil and Gas Conference
PR Newswire - Tue Aug 12, 3:15PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that it will present at EnerCom's The Oil and Gas Conference being held in Denver, Colorado. William L. Transier, chairman, chief executive officer and president, is scheduled to speak on the company's business strategies and operational plans on Wednesday, August 20, 2014 at 10:05am Mountain time.
Endonovo Therapeutics Targets Non-Invasive Treatment for Acute and Chronic Inflammatory Conditions of the Liver
PR Newswire - Wed Apr 08, 8:00AM CDT
LOS ANGELES, April 8, 2015 /PRNewswire/-- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"
, a biotechnology company developing non-invasive, bio-electromagnetic products with anti-inflammatory properties designed to promote regeneration in damaged tissue and organs in animals and humans, today announced its intention to begin pre-clinical testing of its electroceutical technology to treat and reverse acute and chronic inflammatory liver pathologies. This includes the conditions that cause nonalcoholic steatohepatitis (NASH) and human cirrhotic liver disease. Endonovo Therapeutics Enters into a $3 Million Equity Purchase Agreement with Kodiak Capital Group, LLC
Business Wire - Wed Jan 21, 7:30AM CST
Endonovo Therapeutics, Inc. (OTCQB:ENDV) ("Endonovo" or the "Company"
, a biotechnology company developing innovative regenerative therapies, today announced that it has entered into a $3 million equity purchase agreement with Kodiak Capital Group, LLC, a California-based institutional investor. Endonovo Therapeutics Receives Final Commissioned Report Recommendations Regarding FDA Regulatory Pathway for Urinary Incontinence Treatment
Marketwired - Tue Dec 02, 8:06AM CST
Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"
, a biotechnology company developing innovative regenerative therapies, has received a final report from Emergo Group, Inc. ("Emergo" that reviewed, classified and recommended Endonovo's strategy for gaining FDA 510K regulatory clearance of their proprietary bioelectronic technology for the treatment of urinary incontinence in women. AMGN: 163.38 (+1.89)
Endeavour Announces Accelerated Schedule for Chapter 11 Court Hearings and Resignation of William L. Transier as President and Chief Executive Officer
PR Newswire - Thu Nov 13, 3:10PM CST
Endeavour International Corporation (OTC: ENDRQ) (LSE: ENDV) today announced an accelerated timetable for its Chapter 11 proceedings. The Company anticipates scheduling the following hearing dates with the United States Bankruptcy Court for the District of Delaware:
Endeavour Obtains Final Stock and Claims Order for Trading Requirements
PR Newswire - Fri Nov 07, 6:44PM CST
Endeavour International Corporation (OTC: ENDRQ) (LSE: ENDV) announced today that on November 6, 2014, it and certain of its subsidiaries, including Endeavour Operating Corporation (collectively, the "Debtors"
, obtained a final order (the "Order" from the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court", effective as of October 10, 2014, (i) restricting certain transfers of interest in Endeavour common stock and preferred stock and, depending on the Debtors' proposed chapter 11 plan when filed, certain transfers of claims against the Debtors, and (ii) imposing certain notification requirements with respect to substantial owners of Endeavour stock (by class) and substantial owners of claims against the Debtors (namely, Endeavour's 12% First Priority Notes, its 12% Second Priority Notes, and any unsecured claims against the Debtors). The Bankruptcy Court had previously entered an order on an interim basis. The Order is intended to prevent certain transfers of stock of Endeavour and certain transfers of claims against the Debtors that could impair the ability of one or more of the Debtors' estates to use, to the extent otherwise available, their net operating loss carryovers and certain other tax attributes during bankruptcy and on a reorganized basis. Endeavour Obtains Interim Stock and Claims Order for Trading Requirements
PR Newswire - Fri Oct 17, 4:45PM CDT
Endeavour International Corporation (OTC: ENDRQ) (LSE: ENDV) announced today that on October 10, 2014, it and certain of its subsidiaries, including Endeavour Operating Corporation (collectively, the "Debtors"
, filed a motion (the "Motion" with the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court" seeking an order (i) restricting certain transfers of interest in Endeavour common stock and preferred stock and, depending on the Debtors' proposed chapter 11 plan when filed, certain transfers of claims against the Debtors, and (ii) imposing certain notification requirements with respect to substantial owners of Endeavour stock (by class) and substantial owners of claims against the Debtors (namely, Endeavour's 12% First Priority Notes, its 12% Second Priority Notes, and any unsecured claims against the Debtors). The order is intended to prevent certain transfers of stock of Endeavour and certain transfers of claims against the Debtors that could impair the ability of one or more of the Debtors' estates to use, to the extent otherwise available, their net operating loss carryovers and certain other tax attributes during bankruptcy and on a reorganized basis. Endeavour Announces Rochelle Field Has Returned to Production
PR Newswire - Wed Oct 15, 9:30AM CDT
Endeavour International Corporation (OTC Pink: ENDRQ) (LSE: ENDV) today announced that the Rochelle field is back online. Production from the field restarted on October 12, 2014 and is currently producing at 90 million standard cubic feet of gas per day ("MMscf/d"
with approximately 4,600 barrels of per day of associated liquids. Endeavour Executes Restructuring Support Agreement Pursuant to Chapter 11 Proceedings
PR Newswire - Fri Oct 10, 10:51PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that the Company has executed a Restructuring Support Agreement ("RSA"
with holders of more than two-thirds (2/3) of its 12% First Priority Notes, 12% Second Priority Notes, 7.5% Convertible Bonds and 5.5% / 6.5% Convertible Notes (collectively, the "Notes" to restructure the Company's debt obligations. In connection therewith, the Company and certain of its subsidiaries have each filed a voluntary petition for relief under Chapter 11 of the Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware ("Chapter 11 Proceedings". The Company's U.K. subsidiaries and certain other affiliates have not sought bankruptcy protection and will continue to operate outside of any reorganization proceedings. Endeavour and its debtor affiliates will continue to operate as "debtors in possession" in the Chapter 11 Proceedings. Endeavour Announces One Day Forbearance Agreement with Noteholders
PR Newswire - Thu Oct 09, 8:00PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that the Company and certain of its subsidiaries have entered into extensions of their forbearance agreements (the "Forbearance Agreements"
with holders of a majority of its 12% First Priority Notes due 2018, 12% Second Priority Notes due 2018 and 6.5% Convertible Senior Notes due 2016 (collectively, the "Notes". Endeavour Announces the Appointment of a Chief Restructuring Officer
PR Newswire - Mon Oct 06, 4:00PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that the Company has engaged Opportune LLP, to assist the company in its financial restructuring process. In connection with this engagement, David C. Baggett, Managing Partner of Opportune LLP, has been appointed as Chief Restructuring Officer of Endeavour, effective immediately, reporting directly to the Board of Directors.
GEL: 45.84 (+0.19)
Endeavour International Corporation Announces Closing of $440 Million Senior Secured First Lien Term Loan and Forbearance Agreement with Noteholders
PR Newswire - Wed Oct 01, 1:00AM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced the closing of a $440 million senior secured term loan (the "Credit Agreement"
with an annual interest rate of LIBOR plus 10% (with a LIBOR floor of 1%), that matures on January 2, 2017. The proceeds of the financing were used to repay the balance outstanding under the Company's existing credit agreement, dated as of January 24, 2014, to repay in full certain monetary production payments issued by the Company's wholly-owned subsidiary, Endeavour Energy UK Limited ("EEUK", to repay all reimbursement obligations outstanding with respect to the Company's existing LC Procurement Agreement, dated as of January 24, 2014, to provide cash collateral under the terms of a new LC Issuance Agreement entered into by certain subsidiaries of the Company (pursuant to which Credit Suisse AG has agreed to issue letters of credit for EEUK's account to secure decommissioning obligations in connection with certain of its United Kingdom Continental Shelf Petroleum Production Licenses), for payment of related expenses and to provide additional liquidity to the Company. Endeavour Announces Rochelle Field Remains Offline
PR Newswire - Fri Sep 26, 3:30PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that it has been informed by the operator of the Scott platform that the Rochelle field remains offline. Although the repairs of the Scott export compressors were successfully completed, the gas cooler failed a leak test during commissioning.
Endeavour Receives Notice Regarding NYSE Continued Listing Standards
PR Newswire - Wed Sep 17, 3:30PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) announced today that the New York Stock Exchange ("NYSE"
has notified the Company that it is not in compliance with two of the NYSE's continued listing standards. Endeavour Announces Rochelle Field Offline
PR Newswire - Mon Sep 15, 3:30PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that the Rochelle field is offline until repairs to the dry gas export compressors on the Scott platform are completed.
Endeavour Announces Decision Not to Make Interest Payments
PR Newswire - Tue Sep 02, 3:05PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that it has decided not to pay approximately $33.5 million in interest due on September 2, 2014 on its 12% First Priority Notes due March 2018, 12% Second Priority Notes due June 2018 and 6.5% Convertible Senior Notes due November 2017 ("collectively, the Notes"
. Under the term of the indentures for the Notes, there is a 30-day grace period during which the Company may elect to make the interest payment and cure any potential event of default for non-payment. Endonovo Therapeutics Files Patent on Bioelectronic Technology, Devices and Therapies
Marketwire - Tue Sep 02, 8:02AM CDT
Endonovo Therapeutics, Inc. (OTCQB: ENDV), a developer of novel cell-free therapies, announced today that it has filed a patent on bioelectronic technologies, devices and therapies (the "Technology"
. Endonovo Therapeutics Developing Non-Invasive Bioelectronic Therapy for Urinary Incontinence
Marketwire - Thu Aug 14, 8:03AM CDT
Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"
, a developer of non-invasive bioelectronic therapies, announced today that it has retained Holland & Knight, LLP ("H & K" as its legal counsel and Emergo Group, Inc. ("Emergo" to assist the Company in obtaining FDA clearance of its non-invasive urinary incontinence treatment. Endeavour to Present at EnerCom's The Oil and Gas Conference
PR Newswire - Tue Aug 12, 3:15PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that it will present at EnerCom's The Oil and Gas Conference being held in Denver, Colorado. William L. Transier, chairman, chief executive officer and president, is scheduled to speak on the company's business strategies and operational plans on Wednesday, August 20, 2014 at 10:05am Mountain time.
